tdholodok.ru
Log In

The role of polygenic risk and susceptibility genes in breast cancer over the course of life

$ 28.50

4.6 (121) In stock

PDF) The role of polygenic risk and susceptibility genes in breast cancer over the course of life

A polygenic-score-based approach for identification of gene-drug interactions stratifying breast cancer risk - ScienceDirect

Incorporating family history of disease improves polygenic risk scores in diverse populations

Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients, Genome Medicine

Cancers, Free Full-Text

Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients, Genome Medicine

Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence, BMC Medical Genomics

Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence, BMC Medical Genomics

The interplay of polygenic risk, high-impact monogenic variants, and family history

Hereditary Breast Cancer : BRCA and Other Susceptibility Genes

Systematic comparison of family history and polygenic risk across 24 common diseases - ScienceDirect

Frontiers Causal relationships between telomere length and liver disease: a Mendelian randomization study

Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25

The translation of genetic breast cancer screening into the clinic: current challenges and potential benefits – The MedGen Project

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

Related products

When Do A Woman's Breasts Stop Growing?

Genetic testing in inherited breast and ovarian cancer R208

How to Make Your Breasts Bigger Overnight- THE REAL WAY(100% guaranteed), by Voke Victor

Frontiers Diet and Transgenerational Epigenetic Inheritance of Breast Cancer: The Role of the Paternal Germline

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors